Quarterly report pursuant to Section 13 or 15(d)

NET LOSS PER SHARE (Tables)

v3.7.0.1
NET LOSS PER SHARE (Tables)
3 Months Ended
Mar. 31, 2017
Earnings Per Share [Abstract]  
Schedule of anti-dilutive

Dilutive shares which could exist pursuant to the exercise of outstanding stock instruments and which were not included in the calculation because their affect would have been anti-dilutive are as follows:

 

    Three
Months Ended
March 31,
2017
(Shares)
    Three
Months Ended
March 31,
2016
(Shares)
 
             
Restricted stock awards – unvested     -       1,160,000  
Warrants     6,219,200       6,219,200  
      6,219,200       7,379,200